Log In
BCIQ
Print this Print this
 

SKLB1028

  Manage Alerts
Collapse Summary General Information
Company CSPC Pharmaceutical Group Ltd.
DescriptionOral multikinase inhibitor of EGFR, FLT3 and Abl
Molecular Target Epidermal growth factor receptor (EGFR) ; FMS-like tyrosine kinase 3 (FLT3) (CD135)
Mechanism of ActionFMS-like tyrosine kinase 3 (FLT3) inhibitor; Epidermal growth factor (EGF) receptor inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today